 | Adaptimmune Therapeutics plc | |||
| NMS : ADAP || Location: United Kingdom | ||||
$1.06-0.02 (-1.85%) |
0.56 M | 1.04 - 1.1 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 3.408 M |
| March 28, 2024 | 3.197 M |
| March 15, 2024 | 3.112 M |
| Feb. 29, 2024 | 2.800 M |
| Feb. 15, 2024 | 2.929 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | -0.24 | -135.29% |
| 09/30/2023 | -0.14 | -0.20 | -42.55% |
| 06/30/2023 | -0.14 | -0.23 | -69.37% |
| 03/31/2023 | -0.15 | 0.01 | 104.05% |
| 12/31/2022 | -0.25 | -0.18 | 28.94% |
ADAP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 255.562M | Shares Float | 255.562M |
| Short Float | 3.408M | Market Cap | 276.01M |
| Institution ownership | 67.52% | Insider ownership | 0.386% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -0.54 | Forward EPS | -0.42 |